Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 5,101 |
|
|||||
| News | (1) |
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Aclarion Inc | ACONW | NASDAQ | Equity Warrant |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.0046 | -16.60% | 0.023101 | 11:45:30 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.0277 | 0.0212 | 0.0277 | 0.0277 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume |
|---|---|---|---|---|
| 12 | 5,101 | 0.0253039 | 129 | - |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 11:45:30 | 200 | 0.023101 | USD |
Aclarion Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 243.57k | 8.79M | - | 75k | -4.91M | -0.56 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Aclarion
| Date | Time | Source | Heading |
|---|---|---|---|
| 11/04/2024 | 05:15 | Edgar (US Regulatory) | Form S-3 - Registration statement under Securities Act of.. |
| 10/25/2024 | 16:05 | Edgar (US Regulatory) | Form S-1 - General form for registration of securities under.. |
| 10/24/2024 | 23:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness |
| 10/11/2024 | 15:36 | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration.. |
| 10/11/2024 | 15:20 | Edgar (US Regulatory) | Form 8-K - Current report |
| 10/10/2024 | 06:00 | GlobeNewswire Inc. | Aclarion to Participate in the 2024 Maxim Healthcare Virtual.. |
| 10/01/2024 | 15:07 | Edgar (US Regulatory) | Form 8-K - Current report |
| 9/27/2024 | 05:57 | GlobeNewswire Inc. | Aclarion's Nociscan AI Plays Key Role in Advanced.. |
| 9/24/2024 | 15:58 | Edgar (US Regulatory) | Form 8-K - Current report |
| 9/24/2024 | 15:54 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 9/23/2024 | 15:01 | Edgar (US Regulatory) | Form 8-K - Current report |
| 9/19/2024 | 16:02 | Edgar (US Regulatory) | Form S-3/A - Registration statement under Securities Act of.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
ACONW Historical
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 5 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. |
